Novocell, Inc.

Authors: Lewis, Alan J; Carpenter, Melissa; Robins, Allan; Baetge, Emmanuel

Source: Regenerative Medicine, Volume 2, Number 6, November 2007 , pp. 973-978(6)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

Novocell, Inc. is a stem cell engineering company creating, delivering and commercializing cell and drug therapies for diabetes and other chronic diseases. The use of human embryonic stem cells provides a scalable source of any differentiated lineage that has potential for cell replacement therapy, as well as tools for drug discovery to create regenerative medicines.

Document Type: Research article

DOI: http://dx.doi.org/10.2217/17460751.2.6.973

Affiliations: 1: Novocell, Inc., 3550 General Atomics Court, Building 2, Room 503, San Diego, CA 92121, USA., Email: alewis@novocell.com

Publication date: 2007-11-01

More about this publication?

Regenerative Medicine provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats vital to an increasingly time-constrained community.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
E-Access Trials
ingentaconnect is not responsible for the content or availability of external websites